• Je něco špatně v tomto záznamu ?

Increasing procoagulant activity of circulating microparticles in patients living with HIV

S. Snopkova, M. Matyskova, K. Havlickova, J. Jarkovsky, M. Svoboda, J. Zavrelova, R. Svacinka, M. Penka, P. Husa

. 2020 ; 50 (7) : 555-561. [pub] 20191011

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004843

OBJECTIVES: HIV-infected individuals are at higher risk of non-AIDS diseases associated with procoagulant status. Microparticles are elevated in disorders associated with thrombosis (e.g., cardiovascular diseases). We investigated the association between microparticle levels in untreated and treated HIV-infected subjects, and determined the association with immune status, viral replication, and duration of antiretroviral therapy. PATIENTS AND METHODS: We included 144 HIV-infected subjects, including 123 on antiretroviral therapy (ART) and 21 before treatment initiation. A control group of 40 HIV-negative healthy adults matched for age and sex was used for comparison of microparticle levels. Treated subjects were divided into five groups depending on the period of antiretroviral exposure. Statistically significant differences were determined by Kruskal-Wallis test and Chi2 test. The relation between microparticles and other parameters was assessed using Spearman's coefficient of correlation. RESULTS: Microparticle levels were significantly higher in treated and untreated HIV-infected subjects than in non-HIV-infected controls (P<0.001). The microparticle level was similar between the groups on treatment (P=0.913). No association between the microparticle level and CD4+ count, CD4+/CD8+ ratio, number of HIV-1 RNA copies, or duration of exposure to antiretroviral treatment was observed. CONCLUSION: Increased levels of microparticles may be due to processes independent of viral replication and CD4+ cell count, and microparticle release might persist even during viral suppression by antiretroviral treatment. Elevated microparticle levels might occur in response to other triggers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004843
003      
CZ-PrNML
005      
20220127144929.0
007      
ta
008      
220113s2020 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.medmal.2019.09.013 $2 doi
035    __
$a (PubMed)31611134
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Snopkova, S $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic. Electronic address: snopkova.svatava@fnbrno.cz
245    10
$a Increasing procoagulant activity of circulating microparticles in patients living with HIV / $c S. Snopkova, M. Matyskova, K. Havlickova, J. Jarkovsky, M. Svoboda, J. Zavrelova, R. Svacinka, M. Penka, P. Husa
520    9_
$a OBJECTIVES: HIV-infected individuals are at higher risk of non-AIDS diseases associated with procoagulant status. Microparticles are elevated in disorders associated with thrombosis (e.g., cardiovascular diseases). We investigated the association between microparticle levels in untreated and treated HIV-infected subjects, and determined the association with immune status, viral replication, and duration of antiretroviral therapy. PATIENTS AND METHODS: We included 144 HIV-infected subjects, including 123 on antiretroviral therapy (ART) and 21 before treatment initiation. A control group of 40 HIV-negative healthy adults matched for age and sex was used for comparison of microparticle levels. Treated subjects were divided into five groups depending on the period of antiretroviral exposure. Statistically significant differences were determined by Kruskal-Wallis test and Chi2 test. The relation between microparticles and other parameters was assessed using Spearman's coefficient of correlation. RESULTS: Microparticle levels were significantly higher in treated and untreated HIV-infected subjects than in non-HIV-infected controls (P<0.001). The microparticle level was similar between the groups on treatment (P=0.913). No association between the microparticle level and CD4+ count, CD4+/CD8+ ratio, number of HIV-1 RNA copies, or duration of exposure to antiretroviral treatment was observed. CONCLUSION: Increased levels of microparticles may be due to processes independent of viral replication and CD4+ cell count, and microparticle release might persist even during viral suppression by antiretroviral treatment. Elevated microparticle levels might occur in response to other triggers.
650    _2
$a dospělí $7 D000328
650    12
$a hemokoagulace $7 D001777
650    12
$a mikropartikule $7 D055252
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a HIV infekce $x krev $7 D015658
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Matyskova, M $u Department of hematology, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
700    1_
$a Havlickova, K $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
700    1_
$a Jarkovsky, J $u Institute of biostatistics and analyses, Faculty of medicine, Masaryk University Brno, Kamenice 126/3, 62500 Brno, Czech Republic
700    1_
$a Svoboda, M $u Institute of biostatistics and analyses, Faculty of medicine, Masaryk University Brno, Kamenice 126/3, 62500 Brno, Czech Republic
700    1_
$a Zavrelova, J $u Department of hematology, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
700    1_
$a Svacinka, R $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
700    1_
$a Penka, M $u Department of hematology, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
700    1_
$a Husa, P $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
773    0_
$w MED00008638 $t Medecine et maladies infectieuses $x 1769-6690 $g Roč. 50, č. 7 (2020), s. 555-561
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31611134 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127144925 $b ABA008
999    __
$a ok $b bmc $g 1752138 $s 1155992
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 50 $c 7 $d 555-561 $e 20191011 $i 1769-6690 $m Médecine et maladies infectieuses $n Med Mal Infect $x MED00008638
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...